Nonclinical Pharmacology/Toxicology Development of Topical Drugs Intended to Prevent the Transmission of Sexually Transmitted Diseases (STD) and/or for the Development of Drugs Intended to Act as Vaginal Contraceptives
July 2005
Click to view Guidance Document
Nonclinical Pharmacology/Toxicology Development of Topical Drugs Intended to Prevent the Transmission of Sexually Transmitted Diseases (STD) and/or for the Development of Drugs Intended to Act as Vaginal Contraceptives
July 2005 |
In this Technical Brief:
Health Risk(s):
- STDs
- Vaginal Contraceptives
Product Type(s):
- Combination
- Vaginal Contraceptives
- Topical Drugs
Topic(s):
- Pharmacology / Toxicology
- Regulatory Issues
Region(s):
- United States
Full Info:
Resource Type:
Citation:
Division of Reproductive and Urologic Drug Products, Office of Drug Evaluation II, Division of Anti-infective Drug Products
and Division of Antiviral Drug Products, Office of Drug Evaluation IV (2005)
Authors:
Division of Reproductive and Urologic Drug Products, Office of Drug Evaluation II, Division of Anti-infective Drug Products and Division of Antiviral Drug Products, Office of Drug Evaluation IV
Health Risks(s):
- STI / STD
- Unintended Pregnancy
Product type(s):
- Contraceptives
- MPTs
Topic(s):
- MPTs
- Development
- Regulatory
Region(s)
- United States
URL of resource: